Dr Reddys Labs benefits 2% on Finasteride release in US

Healthcare firm Dr Reddy’s Laboratories was the top gainer about the Sensex, rising more than 2 percent on Thursday after the firm launched Finasteride tablets (1 mg), a bioequivalent generic edition of Propecia in america market.


The company’s ANDA for Finasteride tablets has been awarded a 180-time amount of marketing exclusivity in america on January 2.

“The Propecia tablets has US sales of around USD 136 million MAT for the newest 12 months ending October 2012, according to IMS Health,” the ongoing firm said in a discharge.

At 10:36 hours IST, the share gained 2.13 percent to Rs 1,877 on the Bombay STOCK MARKET.


For More Articles: Stock Tips,Best Stock Tips

Source: Moneycontrol



About the Author

Leave A Response